Mouthwashes
Conditions
Interventions
Basic periodontal treatments will be performed on patients. After this stage, individuals will be randomly divided based on a draw with closed, opaque and non-translucent envelopes, in 3 groups accord
G2 - patients who will perform mouthwashes with 0.12% chlorhexidine and G3 - patients who will be treated with PHTALOX®. Each group will be composed of the same number of patients, that is, 10. Patien
E06.721.189.350
Sponsors
Universidade Federal de Alfenas
Universidade Federal de Alfenas
Eligibility
Inclusion criteria
Inclusion criteria: Individuals of both sexes; no history of systemic complications for more than 6 months; no recent drug history; systemically healthy; PD patients.
Exclusion criteria
Exclusion criteria: Individuals who do not wish to complete the treatment protocol; individuals with healthy periodontium; pregnancy; lactation; drug abuse; individuals with systemic changes; individuals who have used antibiotics in the past 3 months; individuals with systemic diseases requiring antibiotic prophylaxis prior to periodontal therapy; immunosuppressed individuals.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| It is expected with the use of a mouthwash containing a PHTALOX® formulation as an adjunct to the treatment of scaling and root planing and maintenance of Periodontal Disease in humans, to find an improvement in the periodontal clinical parameters measured in millimeters with the periodontal probe such as level of clinical insertion, probing depth, in addition to the CPI, O 'LEARY and ISS indexes. | — |
Secondary
| Measure | Time frame |
|---|---|
| No secondary outcomes are expected. | — |
Countries
Brazil
Contacts
Public ContactLeandro Fernandes
Outcome results
None listed